Fellowship · New York, NY
Sponsored by New York Presbyterian Hospital
Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review.
Mayo Clinic proceedings. Digital health · 2024 · 10 citations · Daniel Hall-Flavin
Naltrexone and Alcohol Use.
The American journal of psychiatry · 2022 · 21 citations · Jonathan Avery
Chronic cortisol differentially impacts stem cell-derived astrocytes from major depressive disorder patients.
Translational psychiatry · 2021 · 35 citations · Daniel Hall-Flavin
Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic.
Journal of substance abuse treatment · 2021 · 23 citations · Jonathan Avery
Naltrexone treatment for prolonged grief disorder: study protocol for a randomized, triple-blinded, placebo-controlled trial.
Trials · 2021 · 21 citations · Jonathan Avery
Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.
Translational psychiatry · 2021 · 21 citations · Jonathan Avery
Perspectives and Recommendations from Hospitalized Patients with Substance Use Disorders: A Qualitative Study.
Journal of general internal medicine · 2024 · 4 citations · Jonathan Avery
Factors Having an Impact on Relapse and Survival in Transplant Recipients With Alcohol-Induced Liver Disease.
Mayo Clinic proceedings. Innovations, quality & outcomes · 2021 · 19 citations · Daniel Hall-Flavin